vs
芝商所(CME)与FTI CONSULTING, INC(FCN)财务数据对比。点击上方公司名可切换其他公司
芝商所的季度营收约是FTI CONSULTING, INC的1.9倍($1.9B vs $990.7M),FTI CONSULTING, INC净利率更高(5.5% vs 0.1%,领先5.4%),芝商所同比增速更快(14.5% vs 10.7%),过去两年芝商所的营收复合增速更高(10.8% vs 3.3%)
芝商所是总部位于美国伊利诺伊州芝加哥的金融服务企业,为全球规模最大的金融衍生品交易所运营商,旗下拥有芝加哥商品交易所、芝加哥期货交易所、纽约商业交易所、纽约商品交易所等交易平台,覆盖农产品、货币、能源等品类交易,同时持有标普道琼斯指数27%的股权。
FTI咨询成立于1982年,总部位于美国华盛顿特区,是全球顶尖的金融咨询服务商之一。公司核心业务涵盖企业融资与重组、经济咨询、法务与诉讼咨询、战略传播、科技及战略咨询等领域,在31个国家拥有逾7700名员工。
CME vs FCN — 直观对比
营收规模更大
CME
是对方的1.9倍
$990.7M
营收增速更快
CME
高出3.8%
10.7%
净利率更高
FCN
高出5.4%
0.1%
两年增速更快
CME
近两年复合增速
3.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $1.9B | $990.7M |
| 净利润 | $1.2M | $54.5M |
| 毛利率 | — | 31.1% |
| 营业利润率 | 0.1% | 9.4% |
| 净利率 | 0.1% | 5.5% |
| 营收同比 | 14.5% | 10.7% |
| 净利润同比 | 20.7% | 9.7% |
| 每股收益(稀释后) | — | $1.77 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CME
FCN
| Q1 26 | $1.9B | — | ||
| Q4 25 | $1.6B | $990.7M | ||
| Q3 25 | $1.5B | $956.2M | ||
| Q2 25 | $1.7B | $943.7M | ||
| Q1 25 | $1.6B | $898.3M | ||
| Q4 24 | $1.5B | $894.9M | ||
| Q3 24 | $1.6B | $926.0M | ||
| Q2 24 | $1.5B | $949.2M |
净利润
CME
FCN
| Q1 26 | $1.2M | — | ||
| Q4 25 | $1.2B | $54.5M | ||
| Q3 25 | $908.0M | $82.8M | ||
| Q2 25 | $1.0B | $71.7M | ||
| Q1 25 | $956.2M | $61.8M | ||
| Q4 24 | $874.6M | $49.7M | ||
| Q3 24 | $912.8M | $66.5M | ||
| Q2 24 | $883.2M | $83.9M |
毛利率
CME
FCN
| Q1 26 | — | — | ||
| Q4 25 | — | 31.1% | ||
| Q3 25 | — | 33.3% | ||
| Q2 25 | — | 32.1% | ||
| Q1 25 | — | 32.2% | ||
| Q4 24 | — | 30.2% | ||
| Q3 24 | — | 32.2% | ||
| Q2 24 | — | 32.8% |
营业利润率
CME
FCN
| Q1 26 | 0.1% | — | ||
| Q4 25 | 61.8% | 9.4% | ||
| Q3 25 | 63.3% | 12.3% | ||
| Q2 25 | 66.7% | 10.5% | ||
| Q1 25 | 67.5% | 8.8% | ||
| Q4 24 | 62.1% | 5.9% | ||
| Q3 24 | 64.6% | 9.8% | ||
| Q2 24 | 65.3% | 11.0% |
净利率
CME
FCN
| Q1 26 | 0.1% | — | ||
| Q4 25 | 71.7% | 5.5% | ||
| Q3 25 | 59.1% | 8.7% | ||
| Q2 25 | 60.6% | 7.6% | ||
| Q1 25 | 58.2% | 6.9% | ||
| Q4 24 | 57.3% | 5.6% | ||
| Q3 24 | 57.6% | 7.2% | ||
| Q2 24 | 57.6% | 8.8% |
每股收益(稀释后)
CME
FCN
| Q1 26 | — | — | ||
| Q4 25 | $3.24 | $1.77 | ||
| Q3 25 | $2.49 | $2.60 | ||
| Q2 25 | $2.81 | $2.13 | ||
| Q1 25 | $2.62 | $1.74 | ||
| Q4 24 | $2.40 | $1.39 | ||
| Q3 24 | $2.50 | $1.85 | ||
| Q2 24 | $2.42 | $2.34 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $2.4B | $265.1M |
| 总债务越低越好 | $3.4B | — |
| 股东权益账面价值 | — | $1.7B |
| 总资产 | $202.0B | $3.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
CME
FCN
| Q1 26 | $2.4B | — | ||
| Q4 25 | $4.5B | $265.1M | ||
| Q3 25 | $2.6B | $146.0M | ||
| Q2 25 | $2.1B | $152.8M | ||
| Q1 25 | $1.5B | $151.1M | ||
| Q4 24 | $3.0B | $660.5M | ||
| Q3 24 | $2.4B | $386.3M | ||
| Q2 24 | $1.9B | $226.4M |
总债务
CME
FCN
| Q1 26 | $3.4B | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $60.0M |
股东权益
CME
FCN
| Q1 26 | — | — | ||
| Q4 25 | $28.7B | $1.7B | ||
| Q3 25 | $28.2B | $1.7B | ||
| Q2 25 | $27.7B | $1.9B | ||
| Q1 25 | $27.0B | $2.1B | ||
| Q4 24 | $26.5B | $2.3B | ||
| Q3 24 | $28.2B | $2.3B | ||
| Q2 24 | $27.6B | $2.1B |
总资产
CME
FCN
| Q1 26 | $202.0B | — | ||
| Q4 25 | $198.4B | $3.5B | ||
| Q3 25 | $187.1B | $3.5B | ||
| Q2 25 | $179.9B | $3.5B | ||
| Q1 25 | $157.8B | $3.3B | ||
| Q4 24 | $137.4B | $3.6B | ||
| Q3 24 | $137.8B | $3.5B | ||
| Q2 24 | $123.4B | $3.4B |
负债/权益比
CME
FCN
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.03× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | — | $359.8M |
| 自由现金流经营现金流 - 资本支出 | — | $351.4M |
| 自由现金流率自由现金流/营收 | — | 35.5% |
| 资本支出强度资本支出/营收 | — | 0.8% |
| 现金转化率经营现金流/净利润 | — | 6.60× |
| 过去12个月自由现金流最近4个季度 | — | $93.6M |
8季度趋势,按日历期对齐
经营现金流
CME
FCN
| Q1 26 | — | — | ||
| Q4 25 | $1.1B | $359.8M | ||
| Q3 25 | $968.1M | $201.9M | ||
| Q2 25 | $1.1B | $55.7M | ||
| Q1 25 | $1.1B | $-465.2M | ||
| Q4 24 | $1.0B | $315.3M | ||
| Q3 24 | $1.0B | $219.4M | ||
| Q2 24 | $776.9M | $135.2M |
自由现金流
CME
FCN
| Q1 26 | — | — | ||
| Q4 25 | $1.1B | $351.4M | ||
| Q3 25 | $949.7M | $187.0M | ||
| Q2 25 | $1.0B | $38.3M | ||
| Q1 25 | $1.1B | $-483.0M | ||
| Q4 24 | $991.7M | $301.6M | ||
| Q3 24 | $973.2M | $212.3M | ||
| Q2 24 | $758.7M | $125.2M |
自由现金流率
CME
FCN
| Q1 26 | — | — | ||
| Q4 25 | 66.8% | 35.5% | ||
| Q3 25 | 61.8% | 19.6% | ||
| Q2 25 | 61.5% | 4.1% | ||
| Q1 25 | 67.1% | -53.8% | ||
| Q4 24 | 65.0% | 33.7% | ||
| Q3 24 | 61.4% | 22.9% | ||
| Q2 24 | 49.5% | 13.2% |
资本支出强度
CME
FCN
| Q1 26 | — | — | ||
| Q4 25 | 2.0% | 0.8% | ||
| Q3 25 | 1.2% | 1.6% | ||
| Q2 25 | 1.1% | 1.8% | ||
| Q1 25 | 0.9% | 2.0% | ||
| Q4 24 | 1.7% | 1.5% | ||
| Q3 24 | 1.9% | 0.8% | ||
| Q2 24 | 1.2% | 1.1% |
现金转化率
CME
FCN
| Q1 26 | — | — | ||
| Q4 25 | 0.96× | 6.60× | ||
| Q3 25 | 1.07× | 2.44× | ||
| Q2 25 | 1.03× | 0.78× | ||
| Q1 25 | 1.17× | -7.52× | ||
| Q4 24 | 1.16× | 6.34× | ||
| Q3 24 | 1.10× | 3.30× | ||
| Q2 24 | 0.88× | 1.61× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CME
暂无分部数据
FCN
| Corporate Finance Segment | $423.2M | 43% |
| Forensic And Litigation Consulting | $192.9M | 19% |
| Economic Consulting | $176.2M | 18% |
| Strategic Communications | $99.4M | 10% |
| Other | $99.0M | 10% |